Potential roles of NEDD4 and NEDD4L and their utility as therapeutic targets in high‑incidence adult male cancers (Review)
- Authors:
- Amjad Z. Alrosan
- Khaled Alrosan
- Ghaith B. Heilat
- Rawan Alsharedeh
- Rawan Abudalo
- Muna Oqal
- Abdelrahim Alqudah
- Yasmin A. Elmaghrabi
-
Affiliations: Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa 13133, Jordan, Department of General Surgery and Urology, Faculty of Medicine, The Jordan University of Science and Technology, Irbid 22110, Jordan, Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, The Yarmouk University, Irbid 21163, Jordan, Department of Pharmaceutical Technology, Faculty of Pharmacy, The Hashemite University, Zarqa 13133, Jordan, Wizard Pharmacy Willetton, Perth 6155, Western Australia - Published online on: July 18, 2023 https://doi.org/10.3892/mco.2023.2664
- Article Number: 68
-
Copyright: © Alrosan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Cooper GM: The Cell: A Molecular Approach. 2nd edition. Sunderland (MA): Sinauer Associates. The Development and Causes of Cancer. https://www.ncbi.nlm.nih.gov/books/NBK9963/. 2000. | |
Hanahan D: Hallmarks of cancer: New dimensions. Cancer Discov. 12:31–46. 2022.PubMed/NCBI View Article : Google Scholar | |
American Cancer Society. Cancer Statistics Center. http://cancerstatisticscenter.cancer.org. Accessed Dec 25, 2022. | |
World Health Organization (WHO): Editorial Style Manual WHO, Geneva, p83-91, 1993. | |
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.PubMed/NCBI View Article : Google Scholar | |
Siegel RL, Miller KD, Fuchs HE and Jemal A: Cancer statistics, 2022. CA Cancer J Clin. 72:7–33. 2022.PubMed/NCBI View Article : Google Scholar | |
Bertram JS: The molecular biology of cancer. Mol Aspects Med. 21:167–223. 2000.PubMed/NCBI View Article : Google Scholar | |
Kontomanolis EN, Koutras A, Syllaios A, Schizas D, Mastoraki A, Garmpis N, Diakosavvas M, Angelou K, Tsatsaris G, Pagkalos A, et al: Role of oncogenes and tumor-suppressor genes in carcinogenesis: A review. Anticancer Res. 40:6009–6015. 2020.PubMed/NCBI View Article : Google Scholar | |
Welti J, Loges S, Dimmeler S and Carmeliet P: Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. J Clin Invest. 123:3190–3200. 2013.PubMed/NCBI View Article : Google Scholar | |
Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011.PubMed/NCBI View Article : Google Scholar | |
Hanahan D and Weinberg RA: The hallmarks of cancer. Cell. 100:57–70. 2000.PubMed/NCBI View Article : Google Scholar | |
Kamali H, Golmohammadzadeh S, Zare H, Nosrati R, Fereidouni M and Safarpour H: The recent advancements in the early detection of cancer biomarkers by DNAzyme-assisted aptasensors. J Nanobiotechnology. 20(438)2022.PubMed/NCBI View Article : Google Scholar | |
Pan S and Chen R: Pathological implication of protein post-translational modifications in cancer. Mol Aspects Med. 86(101097)2022.PubMed/NCBI View Article : Google Scholar | |
Hershko A and Ciechanover A: The ubiquitin system. Annu Rev Biochem. 67:425–479. 1998.PubMed/NCBI View Article : Google Scholar | |
Weissman AM: Themes and variations on ubiquitylation. Nat Rev Mol Cell Biol. 2:169–178. 2001.PubMed/NCBI View Article : Google Scholar | |
Komander D and Rape M: The ubiquitin code. Annu Rev Biochem. 81:203–229. 2012.PubMed/NCBI View Article : Google Scholar | |
Salas-Lloret D and González-Prieto R: Insights in post-translational modifications: Ubiquitin and SUMO. Int J Mol Sci. 23(3281)2022.PubMed/NCBI View Article : Google Scholar | |
Liebl MP and Hoppe T: It's all about talking: Two-way communication between proteasomal and lysosomal degradation pathways via ubiquitin. Am J Physiol Cell Physiol. 311:C166–C178. 2016.PubMed/NCBI View Article : Google Scholar | |
Tu Y, Chen C, Pan J, Xu J, Zhou ZG and Wang CY: The Ubiquitin Proteasome Pathway (UPP) in the regulation of cell cycle control and DNA damage repair and its implication in tumorigenesis. Int J Clin Exp Pathol. 5:726–738. 2012.PubMed/NCBI | |
Klionsky DJ and Schulman BA: Dynamic regulation of macroautophagy by distinctive ubiquitin-like proteins. Nat Struct Mol Biol. 21:336–345. 2014.PubMed/NCBI View Article : Google Scholar | |
Kerscher O, Felberbaum R and Hochstrasser M: Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu Rev Cell Dev Biol. 22:159–180. 2006.PubMed/NCBI View Article : Google Scholar | |
Ciechanover A and Kwon YT: Degradation of misfolded proteins in neurodegenerative diseases: Therapeutic targets and strategies. Exp Mol Med. 47(e147)2015.PubMed/NCBI View Article : Google Scholar | |
Berndsen CE and Wolberger C: New insights into ubiquitin E3 ligase mechanism. Nat Struct Mol Biol. 21:301–307. 2014.PubMed/NCBI View Article : Google Scholar | |
Kravtsova-Ivantsiv Y and Ciechanover A: Non-canonical ubiquitin-based signals for proteasomal degradation. J Cell Sci. 125(Pt 3):539–548. 2012.PubMed/NCBI View Article : Google Scholar | |
Buetow L and Huang DT: Structural insights into the catalysis and regulation of E3 ubiquitin ligases. Nat Rev Mol Cell Biol. 17:626–642. 2016.PubMed/NCBI View Article : Google Scholar | |
Rotin D and Kumar S: Physiological functions of the HECT family of ubiquitin ligases. Nat Rev Mol Cell Biol. 10:398–409. 2009.PubMed/NCBI View Article : Google Scholar | |
Metzger MB, Hristova VA and Weissman AM: HECT and RING finger families of E3 ubiquitin ligases at a glance. J Cell Sci. 125(Pt 3):531–537. 2012.PubMed/NCBI View Article : Google Scholar | |
Joazeiro CA and Weissman AM: RING finger proteins: Mediators of ubiquitin ligase activity. Cell. 102:549–552. 2000.PubMed/NCBI View Article : Google Scholar | |
Bernassola F, Karin M, Ciechanover A and Melino G: The HECT family of E3 ubiquitin ligases: Multiple players in cancer development. Cancer Cell. 14:10–21. 2008.PubMed/NCBI View Article : Google Scholar | |
Dove KK, Stieglitz B, Duncan ED, Rittinger K and Klevit RE: Molecular insights into RBR E3 ligase ubiquitin transfer mechanisms. EMBO Rep. 17:1221–1235. 2016.PubMed/NCBI View Article : Google Scholar | |
Li W and Ye Y: Polyubiquitin chains: Functions, structures, and mechanisms. Cell Mol Life Sci. 65:2397–2406. 2008.PubMed/NCBI View Article : Google Scholar | |
Dinudom A, Harvey KF, Komwatana P, Young JA, Kumar S and Cook DI: Nedd4 mediates control of an epithelial Na+ channel in salivary duct cells by cytosolic Na+. Proc Natl Acad Sci USA. 95:7169–7173. 1998.PubMed/NCBI View Article : Google Scholar | |
Goulet CC, Volk KA, Adams CM, Prince LS, Stokes JB and Snyder PM: Inhibition of the epithelial Na+ channel by interaction of Nedd4 with a PY motif deleted in Liddle's syndrome. J Biol Chem. 273:30012–30017. 1998.PubMed/NCBI View Article : Google Scholar | |
Harvey KF, Dinudom A, Komwatana P, Jolliffe CN, Day ML, Parasivam G, Cook DI and Kumar S: All three WW domains of murine Nedd4 are involved in the regulation of epithelial sodium channels by intracellular Na+. J Biol Chem. 274:12525–12530. 1999.PubMed/NCBI View Article : Google Scholar | |
Harvey KF, Dinudom A, Cook DI and Kumar S: The Nedd4-like protein KIAA0439 is a potential regulator of the epithelial sodium channel. J Biol Chem. 276:8597–8601. 2001.PubMed/NCBI View Article : Google Scholar | |
Kanelis V, Farrow NA, Kay LE, Rotin D and Forman-Kay JD: NMR studies of tandem WW domains of Nedd4 in complex with a PY motif-containing region of the epithelial sodium channel. Biochem Cell Biol. 76:341–350. 1998.PubMed/NCBI View Article : Google Scholar | |
Ingham RJ, Gish G and Pawson T: The Nedd4 family of E3 ubiquitin ligases: Functional diversity within a common modular architecture. Oncogene. 23:1972–1984. 2004.PubMed/NCBI View Article : Google Scholar | |
Dodson EJ, Fishbain-Yoskovitz V, Rotem-Bamberger S and Schueler-Furman O: Versatile communication strategies among tandem WW domain repeats. Exp Biol Med (Maywood). 240:351–360. 2015.PubMed/NCBI View Article : Google Scholar | |
Scheffner M and Kumar S: Mammalian HECT ubiquitin-protein ligases: Biological and pathophysiological aspects. Biochim Biophys Acta. 1843:61–74. 2014.PubMed/NCBI View Article : Google Scholar | |
Lee IH, Dinudom A, Sanchez-Perez A, Kumar S and Cook DI: Akt mediates the effect of insulin on epithelial sodium channels by inhibiting Nedd4-2. J Biol Chem. 282:29866–29873. 2007.PubMed/NCBI View Article : Google Scholar | |
Goel P, Manning JA and Kumar S: NEDD4-2 (NEDD4L): The ubiquitin ligase for multiple membrane proteins. Gene. 557:1–10. 2015.PubMed/NCBI View Article : Google Scholar | |
Lu X, Xu H, Xu J, Lu S, You S, Huang X, Zhang N and Zhang L: The regulatory roles of the E3 ubiquitin ligase NEDD4 family in DNA damage response. Front Physiol. 13(968927)2022.PubMed/NCBI View Article : Google Scholar | |
Chaugule VK and Walden H: Specificity and disease in the ubiquitin system. Biochem Soc Trans. 44:212–227. 2016.PubMed/NCBI View Article : Google Scholar | |
Herrmann J, Soares SM, Lerman LO and Lerman A: Potential role of the ubiquitin-proteasome system in atherosclerosis: Aspects of a protein quality disease. J Am Coll Cardiol. 51:2003–2010. 2008.PubMed/NCBI View Article : Google Scholar | |
Potjewyd FM and Axtman AD: Exploration of Aberrant E3 ligases implicated in Alzheimer's disease and development of chemical tools to modulate their function. Front Cell Neurosci. 15(768655)2021.PubMed/NCBI View Article : Google Scholar | |
Sun T, Liu Z and Yang Q: The role of ubiquitination and deubiquitination in cancer metabolism. Mol Cancer. 19(146)2020.PubMed/NCBI View Article : Google Scholar | |
Petroski MD: The ubiquitin system, disease, and drug discovery. BMC Biochem. 9 (Suppl 1)(S7)2008.PubMed/NCBI View Article : Google Scholar | |
Orlowski RZ and Kuhn DJ: Proteasome inhibitors in cancer therapy: Lessons from the first decade. Clin Cancer Res. 14:1649–1657. 2008.PubMed/NCBI View Article : Google Scholar | |
Thandra KC and Barsouk A, Saginala K, Aluru JS and Barsouk A: Epidemiology of lung cancer. Contemp Oncol (Pozn). 25:45–52. 2021.PubMed/NCBI View Article : Google Scholar | |
Zhang J, Cao R, Lian C, Cao T, Shi Y, Ma J, Wang P and Xia J: Nitidine chloride suppresses NEDD4 expression in lung cancer cells. Aging (Albany NY). 13:782–793. 2020.PubMed/NCBI View Article : Google Scholar | |
Rajdev K, Siddiqui AH, Ibrahim U, Patibandla P, Khan T and El-Sayegh D: An unusually aggressive large cell carcinoma of the lung: Undiagnosed until autopsy. Cureus. 10(e2202)2018.PubMed/NCBI View Article : Google Scholar | |
Amodio N, Scrima M, Palaia L, Salman AN, Quintiero A, Franco R, Botti G, Pirozzi P, Rocco G, De Rosa N and Viglietto G: Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas. Am J Pathol. 177:2622–2634. 2010.PubMed/NCBI View Article : Google Scholar | |
Zhang W, Zhang R, Zeng Y, Li Y, Chen Y, Zhou J, Zhang Y, Wang A, Zhu J, Liu Z, et al: ALCAP2 inhibits lung adenocarcinoma cell proliferation, migration and invasion via the ubiquitination of β-catenin by upregulating the E3 ligase NEDD4L. Cell Death Dis. 12(755)2021.PubMed/NCBI View Article : Google Scholar | |
Song YH, Zhang CQ, Chen FF and Lin XY: Upregulation of neural precursor cell expressed developmentally downregulated 4-1 is associated with poor prognosis and chemoresistance in lung adenocarcinoma. Chin Med J (Engl). 131:16–24. 2018.PubMed/NCBI View Article : Google Scholar | |
Chen Z, Fillmore CM, Hammerman PS, Kim CF and Wong KK: Non-small-cell lung cancers: A heterogeneous set of diseases. Nat Rev Cancer. 14:535–546. 2014.PubMed/NCBI View Article : Google Scholar | |
He H, Huang C, Chen Z, Huang H, Wang X and Chen J: An outlined review for the role of Nedd4-1 and Nedd4-2 in lung disorders. Biomed Pharmacother. 125(109983)2020.PubMed/NCBI View Article : Google Scholar | |
Georgescu MM: PTEN tumor suppressor network in PI3K-Akt pathway control. Genes Cancer. 1:1170–1177. 2010.PubMed/NCBI View Article : Google Scholar | |
Wei C, Lin M, Jinjun B, Su F, Dan C, Yan C, Jie Y, Jin Z, Zi-Chun H and Wu Y: Involvement of general control nonderepressible kinase 2 in cancer cell apoptosis by posttranslational mechanisms. Mol Biol Cell. 26:1044–1057. 2015.PubMed/NCBI View Article : Google Scholar | |
Shao G, Wang R, Sun A, Wei J, Peng K, Dai Q, Yang W and Lin Q: The E3 ubiquitin ligase NEDD4 mediates cell migration signaling of EGFR in lung cancer cells. Mol Cancer. 17(24)2018.PubMed/NCBI View Article : Google Scholar | |
Sakashita H, Inoue H, Akamine S, Ishida T, Inase N, Shirao K, Mori M and Mimori K: Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer. Ann Surg Oncol. 20 (Suppl 3):S590–S598. 2013.PubMed/NCBI View Article : Google Scholar | |
Li G, Song Z, Wu C, Li X, Zhao L, Tong B, Guo Z, Sun M, Zhao J, Zhang H, et al: Downregulation of NEDD4L by EGFR signaling promotes the development of lung adenocarcinoma. J Transl Med. 20(47)2022.PubMed/NCBI View Article : Google Scholar | |
Li R, Hu Z, Sun SY, Chen ZG, Owonikoko TK, Sica GL, Ramalingam SS, Curran WJ, Khuri FR and Deng X: Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non-small cell lung cancer. Mol Cancer Ther. 12:2200–2212. 2013.PubMed/NCBI View Article : Google Scholar | |
Xie S, Xia L, Song Y, Liu H, Wang ZW and Zhu X: Insights into the biological role of NEDD4L E3 ubiquitin ligase in human cancers. Front Oncol. 11(774648)2021.PubMed/NCBI View Article : Google Scholar | |
Lai XN, Li J, Tang LB, Chen WT, Zhang L and Xiong LX: MiRNAs and LncRNAs: Dual roles in TGF-β signaling-regulated metastasis in lung cancer. Int J Mol Sci. 21(1193)2020.PubMed/NCBI View Article : Google Scholar | |
Qu MH, Han C, Srivastava AK, Cui T, Zou N, Gao ZQ and Wang QE: miR-93 promotes TGF-β-induced epithelial-to-mesenchymal transition through downregulation of NEDD4L in lung cancer cells. Tumour Biol. 37:5645–5651. 2016.PubMed/NCBI View Article : Google Scholar | |
Bai X, Jing L, Li Y, Li Y, Luo S, Wang S, Zhou J, Liu Z and Diao A: TMEPAI inhibits TGF-β signaling by promoting lysosome degradation of TGF-β receptor and contributes to lung cancer development. Cell Signal. 26:2030–2039. 2014.PubMed/NCBI View Article : Google Scholar | |
Sun A, Zhu J, Xia S, Li Y, Wu T, Shao G, Yang W and Lin Q: MEKK5 interacts with and negatively regulates the E3 ubiquitin ligase NEDD4 for mediating lung cancer cell migration. Life (Basel). 11(1153)2021.PubMed/NCBI View Article : Google Scholar | |
Saginala K and Barsouk A, Aluru JS, Rawla P, Padala SA and Barsouk A: Epidemiology of bladder cancer. Med Sci (Basel). 8(15)2020.PubMed/NCBI View Article : Google Scholar | |
Sanli O, Dobruch J, Knowles MA, Burger M, Alemozaffar M, Nielsen ME and Lotan Y: Bladder cancer. Nat Rev Dis Primers. 3(17022)2017.PubMed/NCBI View Article : Google Scholar | |
Wen W, Li J, Wang L, Xing Y, Li X, Ruan H, Xi X, Xiong J and Kuang R: Inhibition of NEDD4 inhibits cell growth and invasion and induces cell apoptosis in bladder cancer cells. Cell Cycle. 16:1509–1514. 2017.PubMed/NCBI View Article : Google Scholar | |
Wang X, Trotman LC, Koppie T, Alimonti A, Chen Z, Gao Z, Wang J, Erdjument-Bromage H, Tempst P, Cordon-Cardo C, et al: NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell. 128:129–139. 2007.PubMed/NCBI View Article : Google Scholar | |
Mao M, Yang L, Hu J, Liu B, Zhang X, Liu Y, Wang P and Li H: Oncogenic E3 ubiquitin ligase NEDD4 binds to KLF8 and regulates the microRNA-132/NRF2 axis in bladder cancer. Exp Mol Med. 54:47–60. 2022.PubMed/NCBI View Article : Google Scholar | |
Jing W, Wang G, Cui Z, Xiong G, Jiang X, Li Y, Li W, Han B, Chen S and Shi B: FGFR3 Destabilizes PD-L1 via NEDD4 to Control T-cell-mediated bladder cancer immune surveillance. Cancer Res. 82:114–129. 2022.PubMed/NCBI View Article : Google Scholar | |
Zhao H, Zhang J, Fu X, Mao D, Qi X, Liang S, Meng G, Song Z, Yang R, Guo Z, et al: Integrated bioinformatics analysis of the NEDD4 family reveals a prognostic value of NEDD4L in clear-cell renal cell cancer. PeerJ. 9(e11880)2021.PubMed/NCBI View Article : Google Scholar | |
Hu XY, Xu YM, Fu Q, Yu JJ and Huang J: Nedd4L expression is downregulated in prostate cancer compared to benign prostatic hyperplasia. Eur J Surg Oncol. 35:527–531. 2009.PubMed/NCBI View Article : Google Scholar | |
Negoita S, Feuer EJ, Mariotto A, Cronin KA, Petkov VI, Hussey SK, Benard V, Henley SJ, Anderson RN, Fedewa S, et al: Annual report to the nation on the status of cancer, part II: Recent changes in prostate cancer trends and disease characteristics. Cancer. 124:2801–2814. 2018.PubMed/NCBI View Article : Google Scholar | |
Butler SS, Muralidhar V, Zhao SG, Sanford NN, Franco I, Fullerton ZH, Chavez J, D'Amico AV, Feng FY, Rebbeck TR, et al: Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012. Cancer. 126:717–724. 2020.PubMed/NCBI View Article : Google Scholar | |
Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 66:271–289. 2016.PubMed/NCBI View Article : Google Scholar | |
McCrea E, Sissung TM, Price DK, Chau CH and Figg WD: Androgen receptor variation affects prostate cancer progression and drug resistance. Pharmacol Res. 114:152–162. 2016.PubMed/NCBI View Article : Google Scholar | |
Zhang Y, Duan H, Zhao H, Qi L, Liu Y, Zhang Z, Liu C, Chen L, Jin M, Guan Y, et al: Development and evaluation of a PSMA-targeted nanosystem co-packaging docetaxel and androgen receptor siRNA for castration-resistant prostate cancer treatment. Pharmaceutics. 14(964)2022.PubMed/NCBI View Article : Google Scholar | |
Zhao Y, Li J, Chen J, Ye M and Jin X: Functional roles of E3 ubiquitin ligases in prostate cancer. J Mol Med (Berl). 100:1125–1144. 2022.PubMed/NCBI View Article : Google Scholar | |
Li H, Xu LL, Masuda K, Raymundo E, McLeod DG, Dobi A and Srivastava S: A feedback loop between the androgen receptor and a NEDD4-binding protein, PMEPA1, in prostate cancer cells. J Biol Chem. 283:28988–28995. 2008.PubMed/NCBI View Article : Google Scholar | |
Zhang J, Xie JJ, Zhou SJ, Chen J, Hu Q, Pu JX and Lu JL: Diosgenin inhibits the expression of NEDD4 in prostate cancer cells. Am J Transl Res. 11:3461–3471. 2019.PubMed/NCBI | |
Kim SE, Paik HY, Yoon H, Lee JE, Kim N and Sung MK: Sex- and gender-specific disparities in colorectal cancer risk. World J Gastroenterol. 21:5167–5175. 2015.PubMed/NCBI View Article : Google Scholar | |
Xi Y and Xu P: Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 14(101174)2021.PubMed/NCBI View Article : Google Scholar | |
Rattray NJW, Charkoftaki G, Rattray Z, Hansen JE, Vasiliou V and Johnson CH: Environmental influences in the etiology of colorectal cancer: The premise of metabolomics. Curr Pharmacol Rep. 3:114–125. 2017.PubMed/NCBI View Article : Google Scholar | |
Parmar S and Easwaran H: Genetic and epigenetic dependencies in colorectal cancer development. Gastroenterol Rep (Oxf). 10(goac035)2022.PubMed/NCBI View Article : Google Scholar | |
Hsieh MH, Kung PT, Kuo WY, Ke TW and Tsai WC: Recurrence, death risk, and related factors in patients with stage 0 colorectal cancer: A nationwide population-based study. Medicine (Baltimore). 99(e21688)2020.PubMed/NCBI View Article : Google Scholar | |
Mishra J, Drummond J, Quazi SH, Karanki SS, Shaw JJ, Chen B and Kumar N: Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis. Crit Rev Oncol Hematol. 86:232–250. 2013.PubMed/NCBI View Article : Google Scholar | |
Golshani G and Zhang Y: Advances in immunotherapy for colorectal cancer: A review. Therap Adv Gastroenterol. 13(1756284820917527)2020.PubMed/NCBI View Article : Google Scholar | |
Eide PW, Cekaite L, Danielsen SA, Eilertsen IA, Kjenseth A, Fykerud TA, Ågesen TH, Bruun J, Rivedal E, Lothe RA and Leithe E: NEDD4 is overexpressed in colorectal cancer and promotes colonic cell growth independently of the PI3K/PTEN/AKT pathway. Cell Signal. 25:12–18. 2013.PubMed/NCBI View Article : Google Scholar | |
Aikemu B, Shao Y, Yang G, Ma J, Zhang S, Yang X, Hong H, Yesseyeva G, Huang L, Jia H, et al: NDRG1 regulates Filopodia-induced Colorectal Cancer invasiveness via modulating CDC42 activity. Int J Biol Sci. 17:1716–1730. 2021.PubMed/NCBI View Article : Google Scholar | |
Zou X, Levy-Cohen G and Blank M: Molecular functions of NEDD4 E3 ubiquitin ligases in cancer. Biochim Biophys Acta. 1856:91–106. 2015.PubMed/NCBI View Article : Google Scholar | |
Zhang S, Yu C, Yang X, Hong H, Lu J, Hu W, Hao X, Li S, Aikemu B, Yang G, et al: N-myc downstream-regulated gene 1 inhibits the proliferation of colorectal cancer through emulative antagonizing NEDD4-mediated ubiquitylation of p21. J Exp Clin Cancer Res. 38(490)2019.PubMed/NCBI View Article : Google Scholar | |
Lu C, Thoeni C, Connor A, Kawabe H, Gallinger S and Rotin D: Intestinal knockout of Nedd4 enhances growth of Apcmin tumors. Oncogene. 35:5839–5849. 2016.PubMed/NCBI View Article : Google Scholar | |
Tanksley JP, Chen X and Coffey RJ: NEDD4L is downregulated in colorectal cancer and inhibits canonical WNT signaling. PLoS One. 8(e81514)2013.PubMed/NCBI View Article : Google Scholar | |
Liu J, Shaik S, Dai X, Wu Q, Zhou X, Wang Z and Wei W: Targeting the ubiquitin pathway for cancer treatment. Biochim Biophys Acta. 1855:50–60. 2015.PubMed/NCBI View Article : Google Scholar | |
Wang K, Yu Y, Wang W, Jiang Y, Li Y, Jiang X, Qiao Y, Chen L, Zhao X, Liu J, et al: Targeting the E3 ligase NEDD4 as a novel therapeutic strategy for IGF1 signal pathway-driven gastric cancer. Oncogene. 42:1072–1087. 2023.PubMed/NCBI View Article : Google Scholar | |
Ahn Y, Hwang CY, Lee SR, Kwon KS and Lee C: The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4. Biochem J. 412:331–338. 2008.PubMed/NCBI View Article : Google Scholar | |
Ao N, Chen Q and Liu G: The small molecules targeting ubiquitin-proteasome system for cancer therapy. Comb Chem High Throughput Screen. 20:403–413. 2017.PubMed/NCBI View Article : Google Scholar | |
Wang X, Duan J, Fu W, Yin Z, Sheng J, Lei Z and Wang H: Decreased expression of NEDD4L contributes to NSCLC progression and metastasis. Biochem Biophys Res Commun. 513:398–404. 2019.PubMed/NCBI View Article : Google Scholar | |
Yue M, Yun Z, Li S, Yan G and Kang Z: NEDD4 triggers FOXA1 ubiquitination and promotes colon cancer progression under microRNA-340-5p suppression and ATF1 upregulation. RNA Biol. 18:1981–1995. 2021.PubMed/NCBI View Article : Google Scholar | |
Kim SS, Yoo NJ, Jeong EG, Kim MS and Lee SH: Expression of NEDD4-1, a PTEN regulator, in gastric and colorectal carcinomas. APMIS. 116:779–784. 2008.PubMed/NCBI View Article : Google Scholar |